Division of Clinical Pharmacology

September 27, 2012

AAMC meet highlights need for research funds

During a meeting in Nashville last week, the director of the National Institutes of Health (NIH) called on academic medical centers to make the case for continued, strong federal investment in biomedical research.

By Bill Snyder
September 6, 2012

Personalized medicine focus of Chancellor’s Lecture

The first Chancellor’s Lecture of the academic year, entitled “Genomes, Hype and a Realistic Pathway to Personalized Medicine,” will be given Wednesday, Sept. 12, by Dan Roden, M.D., assistant vice chancellor for Personalized Medicine at Vanderbilt University.

By Bill Snyder
September 6, 2012

BioVU reaches new benchmark in DNA samples

This month BioVU logged in its 150,000th unique genetic sample. It is now the world’s largest collection of human DNA linked to searchable, electronic health information.

By Bill Snyder
August 10, 2012

Key to a woman’s heart (condition)?

Females may be at higher risk of potentially fatal heart condition due to gender differences in a protein involved in the heart’s electrical activity.

By VUMC News and Communications
August 2, 2012

VU hosts international vascular biology research meeting

More than 100 students, faculty and scientists from around the world attended a four-day program on vascular biology research last week at Vanderbilt University.

By Bill Snyder
March 9, 2012

Combo combats dizziness

Some patients may need a combo of medications to combat a condition that causes dizziness.

By VUMC News and Communications
February 22, 2012

Next My Health Chat: ‘Your Genome and the Future of Medicine’

By VUMC News and Communications
December 6, 2011

Study points to personal treatment for atrial fibrillation

Individuals with atrial fibrillation who have a particular genetic variant respond better to rate control therapy.
By Kathy Whitney
October 28, 2011

Vanderbilt doctors to screen patients taking statins for genetic risk factors

Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death.
By Craig Boerner
April 15, 2011

Vanderbilt: Laboratory for health care reform

By Bill Snyder